Package 69097-426-02

{"route": ["ORAL"], "spl_id": "f11e1153-612f-4924-86b1-6739d755e3c1", "openfda": {"upc": ["0369097425029", "0369097426026", "0369097426057"], "unii": ["5968Y6H45M"], "rxcui": ["485434", "485436"], "spl_set_id": ["d59e9ea4-09ea-47bd-af2f-39f7a2e2aceb"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-426-02)", "package_ndc": "69097-426-02", "marketing_start_date": "20161206"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-426-05)", "package_ndc": "69097-426-05", "marketing_start_date": "20161206"}], "brand_name": "ENTECAVIR", "product_id": "69097-426_f11e1153-612f-4924-86b1-6739d755e3c1", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Analog [EXT]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "69097-426", "generic_name": "ENTECAVIR", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ENTECAVIR", "active_ingredients": [{"name": "ENTECAVIR", "strength": ".5 mg/1"}], "application_number": "ANDA206872", "marketing_category": "ANDA", "marketing_start_date": "20161206", "listing_expiration_date": "20261231"}